| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Dorothy Sit | |
| P2860 | cites work | Strategies to Reduce Misdiagnosis of Bipolar Depression | Q22241851 |
| Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial | Q28143204 | ||
| Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group | Q28375949 | ||
| An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). | Q30482552 | ||
| Mood stabilizers during breastfeeding: a review | Q33331897 | ||
| A review of bipolar disorder among adults | Q33535961 | ||
| Metabolism and excretion of mood stabilizers and new anticonvulsants | Q33668218 | ||
| Controlled trials in bipolar I depression: focus on switch rates and efficacy | Q33753303 | ||
| Agitated depression as a mixed state and the problem of melancholia | Q33768213 | ||
| A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 | ||
| The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases | Q33963449 | ||
| The long-term course of rapid-cycling bipolar disorder | Q33968228 | ||
| Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials | Q33975437 | ||
| Omega-3 fatty acids in psychiatry: a review | Q34030375 | ||
| Bipolar depression: pharmacotherapy and related therapeutic strategies | Q34052825 | ||
| Transfer of drugs and other chemicals into human milk | Q34089033 | ||
| Use of electroconvulsive therapy during pregnancy | Q34331167 | ||
| Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis | Q34352552 | ||
| Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases | Q34523758 | ||
| A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year | Q34531152 | ||
| Managing bipolar disorder during pregnancy: weighing the risks and benefits | Q34708409 | ||
| Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. | Q34735182 | ||
| Carbamazepine and valproate in the maintenance treatment of bipolar disorder. | Q34976779 | ||
| An evidence-based review of psychosocial treatments for bipolar disorder. | Q34979410 | ||
| A review of the effect of atypical antipsychotics on weight | Q35035150 | ||
| Treatment of bipolar disorder. | Q35117016 | ||
| Rapid-cycling bipolar disorder: effects of long-term treatments | Q35154713 | ||
| Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life | Q35177802 | ||
| A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders | Q35179904 | ||
| Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease | Q35189661 | ||
| Poststroke depression: prevalence, diagnosis, treatment, and disease progression | Q35189676 | ||
| Antidepressants in bipolar disorder: the case for caution | Q35592492 | ||
| Management of bipolar disorder during pregnancy and the postpartum period | Q35729488 | ||
| Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication | Q36064075 | ||
| The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. | Q36486868 | ||
| Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder | Q37152810 | ||
| Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment | Q37402290 | ||
| Lithium treatment during pregnancy, delivery, and lactation: an update | Q37960625 | ||
| The bipolar spectrum: a review of current concepts and implications for the management of depression in primary care | Q38553959 | ||
| Family and genetic studies of affective disorders | Q39628651 | ||
| Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients | Q40736450 | ||
| Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience | Q40808838 | ||
| The epidemiology of bipolar affective disorder | Q40944729 | ||
| Women with bipolar illness: clinical and research issues | Q40945035 | ||
| Antidepressant-induced mania and cycle acceleration: a controversy revisited | Q40977115 | ||
| The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. | Q41033540 | ||
| Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. | Q51968509 | ||
| Polarity sequence, depression, and chronicity in bipolar I disorder. | Q51986441 | ||
| The epidemiology of DSM-III-R bipolar I disorder in a general population survey. | Q53357821 | ||
| Treatment of Refractory Rapid Cycling Bipolar Disorder With Risperidone | Q57612984 | ||
| Prevalence of migraine in bipolar disorder | Q59706991 | ||
| Switching From 'Unipolar' to Bipolar II | Q60447092 | ||
| Bipolar I: A Five-Year Prospective Follow-up | Q60447096 | ||
| The course of affective disorders. II. Typology of bipolar manic-depressive illness | Q67402192 | ||
| Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders | Q70729881 | ||
| The relative prophylactic efficacy of lithium against manic and depressive recurrences in bipolar patients | Q71399644 | ||
| Postpartum prophylaxis for women with bipolar disorder | Q71553433 | ||
| Clozapine in rapid cycling bipolar disorder | Q71599747 | ||
| Differences and similarities in mixed and pure mania | Q71993596 | ||
| Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants | Q72078495 | ||
| Testing definitions of dysphoric mania and hypomania: prevalence, clinical characteristics and inter-episode stability | Q72536924 | ||
| Risk-benefit decision making for treatment of depression during pregnancy | Q73247015 | ||
| Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance | Q73441541 | ||
| Bipolar depression: an underestimated treatment challenge | Q73600638 | ||
| The clinical features of bipolar depression: a comparison with matched major depressive disorder patients | Q73762145 | ||
| A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder | Q73918315 | ||
| The impact of reproductive events on the course of bipolar disorder in women | Q74069475 | ||
| Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania | Q74176274 | ||
| Bipolar disorder | Q77549686 | ||
| Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology | Q77578859 | ||
| Post-partum psychoses. Clinical diagnoses and relative risk of admission after parturition | Q77601094 | ||
| Treatment delays in bipolar disorders | Q77750747 | ||
| Response to lithium maintenance treatment in bipolar disorders: comparison of women and men | Q77790335 | ||
| The prevalence of migraine in patients with bipolar and unipolar affective disorders | Q77790930 | ||
| Gender differences in bipolar II and unipolar depressed outpatients: a 557-case study | Q78107129 | ||
| Prevalence and clinical features of atypical depression in depressed outpatients: a 467-case study | Q78245807 | ||
| Gender and bipolar illness | Q41740628 | ||
| A double-blind trial of bupropion versus desipramine for bipolar depression | Q42282008 | ||
| Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania | Q42608014 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Clozapine in the treatment of refractory psychotic mania | Q42627098 | ||
| Agitated depression in bipolar I disorder: prevalence, phenomenology, and outcome | Q43422947 | ||
| Age onset of psychotic versus non-psychotic bipolar illness in men and in women | Q43428547 | ||
| Epidemiology of puerperal psychoses | Q43509819 | ||
| Relapse and impairment in bipolar disorder | Q43514252 | ||
| Characterizing female bipolar alcoholic patients presenting for initial evaluation | Q43661380 | ||
| The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. | Q43682742 | ||
| Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function | Q43843051 | ||
| Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder | Q43947453 | ||
| Early physical and sexual abuse associated with an adverse course of bipolar illness | Q43962518 | ||
| Verapamil treatment for women with bipolar disorder | Q43975773 | ||
| Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. | Q44268849 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
| Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder | Q44427295 | ||
| Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study | Q44495168 | ||
| Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants | Q44538144 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Suicide risk in bipolar disorder during treatment with lithium and divalproex | Q44586528 | ||
| Seasonal variations in hospital admissions for affective disorders by gender and ethnicity | Q44647557 | ||
| Antidepressant treatment in bipolar versus unipolar depression | Q44710957 | ||
| The clinical epidemiology of pure and mixed manic episodes | Q45126967 | ||
| Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic | Q45220527 | ||
| Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group | Q45337994 | ||
| Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). | Q46116103 | ||
| The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
| Menstrual cycle related mood changes in women with bipolar disorder | Q46396389 | ||
| Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. | Q46507616 | ||
| Olanzapine increases weight and serum triglyceride levels. | Q47252169 | ||
| Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. | Q47260401 | ||
| Olanzapine-exposed pregnancies and lactation: early experience | Q47665193 | ||
| Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients | Q48114087 | ||
| Beyond lithium in the treatment of bipolar illness | Q48435421 | ||
| Occurrence of subcortical hyperintensities in elderly subjects with mania | Q48615182 | ||
| Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations | Q48769893 | ||
| Rapid cycling in women and men with bipolar manic-depressive disorders. | Q50863185 | ||
| Gender differences in patients with bipolar disorder influence outcome in the medical outcomes survey (SF-20) subscale scores. | Q50881952 | ||
| Recurrence in affective disorder. II. Effect of age and gender. | Q50897597 | ||
| A prospective follow-up of patients with bipolar and primary unipolar affective disorder. | Q51053324 | ||
| Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. | Q51053741 | ||
| Lack of relationship between menstrual cycle phase and mood in a sample of women with rapid cycling bipolar disorder. | Q51088263 | ||
| Valproate, bipolar disorder and polycystic ovarian syndrome. | Q51537591 | ||
| Prevalence, Clinical Correlates, and Treatment of Migraine in Bipolar Disorder | Q51946593 | ||
| Age-dependence of Schneiderian psychotic symptoms in bipolar patients. | Q51948949 | ||
| Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. | Q51949078 | ||
| High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. | Q51957863 | ||
| P433 | issue | 2 | |
| P921 | main subject | bipolar disorder | Q131755 |
| lifetime | Q22675021 | ||
| P304 | page(s) | 91-100 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal of the American Medical Women's Association | Q26839958 |
| P1476 | title | Women and bipolar disorder across the life span | |
| P478 | volume | 59 |
| Q33772103 | Bipolar in Women: Any Gender-based Difference? |
| Q43704138 | Evaluation of Bipolar Disorder in Several Relapses over Time Using Generalized Estimating Equations |
| Q33703868 | Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus |
| Q36696405 | Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study |
| Q60646347 | Spezifische Behandlungsaspekte bipolar erkrankter Frauen |
| Q90715297 | Validity of the WHIPLASHED as a tool to identify bipolar disorder in women |
| Q88086377 | Weighing the Risks: the Management of Bipolar Disorder During Pregnancy |
Search more.